Vaxcyte, Inc. (PCVX)

71.38 +6.36 (+9.79%) USD  |  NASDAQ  |  Oct 09, 16:00
71.27 -0.11 (-0.15%) After-Hours: 20:00
More

Vaxcyte EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for PCVX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
October 06, 2026 --
September 28, 2026 --
September 25, 2026 --
September 06, 2026 --
August 17, 2026 --
August 06, 2026 --
August 05, 2026 --
July 13, 2026 --
June 18, 2026 --
May 08, 2026 --
May 07, 2026 --
May 06, 2026 --
March 25, 2026 --
March 10, 2026 --
February 26, 2026 --
February 25, 2026 --
January 23, 2026 --
December 08, 2025 --
December 01, 2025 --
Date Value
November 06, 2025 --
November 05, 2025 --
September 12, 2025 --
August 07, 2025 --
May 08, 2025 --
April 22, 2025 --
April 10, 2025 --
April 01, 2025 --
March 31, 2025 --
February 26, 2025 --
December 20, 2024 --
September 09, 2024 --
September 05, 2024 --
September 03, 2024 --
August 26, 2024 --
August 07, 2024 --
June 28, 2024 --
May 10, 2024 --
May 09, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
Moderna, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade

EPS Estimates for Next Quarter Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade